Michael R Megna, Chief Accounting Officer at Kiniksa Pharmaceuticals International, sold KNSA on Sep 3, 2026
Data as of Oct 27
▼ SELL$369K4,600 shares at $80.30Michael R Megna Chief Accounting OfficerKNSA Kiniksa Pharmaceuticals International, plc
- Traded
- Sep 3, 2026
- Disclosed
- Sep 3, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
KNSA since disclosure
+10.8%
after the sale
Similar stocks (XLV) since disclosure
+3.4%
XLV — its sector index fund
Change in closing price from Sep 3, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.